- Home
- AAON vs GRFS Comparison
AAON vs GRFS Comparison
Compare AAON & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAON
- GRFS
- Stock Information
- Founded
- AAON 1988
- GRFS 1940
- Country
- AAON United States
- GRFS Spain
- Employees
- AAON N/A
- GRFS N/A
- Industry
- AAON Industrial Machinery/Components
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- AAON Industrials
- GRFS Health Care
- Exchange
- AAON Nasdaq
- GRFS Nasdaq
- Market Cap
- AAON 7.2B
- GRFS 6.0B
- IPO Year
- AAON N/A
- GRFS 2006
- Fundamental
- Price
- AAON $133.18
- GRFS $9.55
- Analyst Decision
- AAON Buy
- GRFS Sell
- Analyst Count
- AAON 4
- GRFS 2
- Target Price
- AAON $133.00
- GRFS $10.50
- AVG Volume (30 Days)
- AAON 450.7K
- GRFS 966.0K
- Earning Date
- AAON 11-07-2024
- GRFS 01-01-0001
- Dividend Yield
- AAON 0.24%
- GRFS N/A
- EPS Growth
- AAON 11.31
- GRFS N/A
- EPS
- AAON 2.28
- GRFS 0.27
- Revenue
- AAON $1,209,555,000.00
- GRFS $7,814,096,584.00
- Revenue This Year
- AAON $6.72
- GRFS $8.86
- Revenue Next Year
- AAON $18.04
- GRFS $7.00
- P/E Ratio
- AAON $58.41
- GRFS $41.94
- Revenue Growth
- AAON 8.34
- GRFS 7.21
- 52 Week Low
- AAON $61.09
- GRFS $5.30
- 52 Week High
- AAON $144.07
- GRFS $12.15
- Technical
- Relative Strength Index (RSI)
- AAON 67.37
- GRFS 62.05
- Support Level
- AAON $112.20
- GRFS $8.69
- Resistance Level
- AAON $144.07
- GRFS $9.96
- Average True Range (ATR)
- AAON 5.13
- GRFS 0.38
- MACD
- AAON 1.81
- GRFS 0.06
- Stochastic Oscillator
- AAON 65.83
- GRFS 77.84
About AAON AAON Inc.
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. AAON's products serve the commercial and industrial new construction and replacement markets, primarily in North America.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.